A tincture of hepcidin cures all: the potential for hepcidin therapeutics.

Iron overload as a result of blood transfusions and excessive intestinal iron absorption can be a complication of chronic anemias such as β-thalassemia. Inappropriately low levels of hepcidin, a negative regulator of iron absorption and recycling, underlie the pathophysiology of the intestinal hyperabsorption. In this issue of the JCI, Gardenghi et al. demonstrate that increasing hepcidin expression to induce iron deficiency in murine β-thalassemia not only mitigates the iron overload, but also the severity of the anemia. These data illustrate the therapeutic potential of modulating hepcidin expression in diseases associated with altered iron metabolism.

[1]  S. Rivella,et al.  Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice. , 2010, The Journal of clinical investigation.

[2]  K. Yoshizaki,et al.  Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease. , 2010, Blood.

[3]  P. Rotwein,et al.  Soluble Repulsive Guidance Molecule c/Hemojuvelin Is a Broad Spectrum Bone Morphogenetic Protein (BMP) Antagonist and Inhibits both BMP2- and BMP6-mediated Signaling and Gene Expression* , 2010, The Journal of Biological Chemistry.

[4]  S. Vaulont,et al.  Oncostatin M is a potent inducer of hepcidin, the iron regulatory hormone , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  Jeffery L. Miller,et al.  Iron Loading and Overloading due to Ineffective Erythropoiesis , 2010, Advances in hematology.

[6]  C. Begley,et al.  Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia. , 2010, Blood.

[7]  M. Méndez,et al.  Hepcidin treatment in Hfe−/− mice diminishes plasma iron without affecting erythropoiesis , 2010, European journal of clinical investigation.

[8]  L. Mei,et al.  Neogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasis. , 2010, Blood.

[9]  Charles B. Hall,et al.  Transferrin therapy ameliorates disease in β-thalassemic mice , 2010, Nature Medicine.

[10]  M. Hashizume,et al.  Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production , 2010, Rheumatology International.

[11]  P. Brissot,et al.  Natural and synthetic STAT3 inhibitors reduce hepcidin expression in differentiated mouse hepatocytes expressing the active phosphorylated STAT3 form , 2010, Journal of Molecular Medicine.

[12]  J. Kanda,et al.  Oncostatin M and leukemia inhibitory factor increase hepcidin expression in hepatoma cell lines , 2009, International journal of hematology.

[13]  Charles C Hong,et al.  Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. , 2008, Nature chemical biology.

[14]  M. Fleming.  The regulation of hepcidin and its effects on systemic and cellular iron metabolism. , 2008, Hematology. American Society of Hematology. Education Program.

[15]  A. Mckie,et al.  Leptin increases the expression of the iron regulatory hormone hepcidin in HuH7 human hepatoma cells. , 2007, The Journal of nutrition.

[16]  Xiaoling Xu,et al.  A Role of Smad4 in Iron Metabolism through the Positive Regulation of Hepcidin Expression , 2022 .

[17]  N. Andrews,et al.  Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis , 2003, Nature Genetics.

[18]  N. Andrews.  Disorders of iron metabolism. , 1999, The New England journal of medicine.

[19]  B. Ramot,et al.  Globin synthesis in iron-deficiency anemia. , 1974, Blood.